PLX.TA

Protalix Biotherapeutics Inc · Healthcare · Biotechnology

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$42.03B

PE Ratio

-28.158092047966772

EV to Ebitda

—

Earnings Yield

-3.55%

Revenue (TTM)

$13.4M

Net Income (TTM)

$-4.2M

Revenue (Annual YoY Growth)

—

Revenue (Quarterly YoY Growth)

0.80%

Profit Margin

-31.33%

Return on Equity

—

Debt to Equity Ratio

—

Dividend Yield

0.00%

All fundamentals

Core6 fields›

Market Cap$42.03B

Revenue TTM$13.4M

Shares Outstanding57.4M

Float0

Insider Ownership15.53%

Institutional Ownership8.64%

Growth Estimates6 fields›

Revenue Growth (Quarterly YoY)0.80%

EPS Growth (Quarterly YoY)-39.20%

EPS Growth Est Quarterly0

EBITDA Growth (Quarterly YoY)-58.45%

CFO Growth (Quarterly YoY)-48.67%

FCF Growth (Quarterly YoY)-48.98%

Operations22 fields›

Revenue TTM$13.4M

Gross Margin TTM58.87%

Gross Margin (Quarterly)72.18%

Operating Margin TTM-27.32%

Operating Margin (Quarterly)-28.95%

Operating Expenses TTM$0.71M

Profit Margin TTM-31.33%

Profit Margin (Quarterly)-43.40%

Net Income TTM$-4.2M

EPS TTM-1.11

EPS (Quarterly)-0.06517836914658162

EBIT Margin TTM-31.86%

EBITDA Margin TTM-25.04%

EBITDA Margin (Quarterly)-26.52%

EBITDA TTM$-3.3M

CFO % of Revenue TTM-52.48%

CFO % of Revenue (Quarterly)-30.30%

CFO TTM$-7.0M

Capex % of Revenue TTM1.32%

Capital Expenditures$0.18M

FCF % of Revenue (Quarterly)-53.80%

FCF TTM$-7.2M

Efficiency1 fields›

ROA-12.57%

Valuation11 fields›

P/E (TTM)-28.158092047966772

P/E Forward119.0476

P/CFO-16.8126336

P/FCF-16.400649289839237

EV/Revenues (TTM)5.1407

Price To Book-39.503368421052635

Price to Tangible Book-39.503368421052635

Earnings Yield-3.55%

FCF Yield-6.10%

Dividend Yield0.00%

Payout Ratio0.00%

Liquidity5 fields›

Current Ratio1.3839464676678281

Total Assets$15.7M

Total Liabilities$78.9M

Shareholders Equity$-3.0M

Interest Expense$0.71M

Yields4 fields›

Dividend Yield0.00%

Payout Ratio0.00%

Earnings Yield-3.55%

Buyback Yield18.07%